SUPN

Supernus Pharmaceuticals, Inc. (SUPN) Economic Moat Analysis (2026)

Invetso Score: 4.8/10 — Balanced · Last Updated: 2026-08-01

Overall Score

Profitability Returns

Gross margin remains very high at 88.1%, but operating margin is still negative at -13.5% and net margin is -13.2%.

Returns remain weak with ROIC at -9.1%, ROE at -10.4%, and ROA at -7.7%, indicating the business is not yet converting its gross profit into durable bottom-line returns.

Scale Efficiency

Revenue per share is $14.30 and asset turnover is 0.58x, showing decent asset utilization despite weak profitability.

The operating cycle remains long at 402.3 days and cash conversion cycle is 381.7 days, reflecting slow working-capital conversion.

Balance Sheet Strength

Liquidity is solid with a current ratio of 2.08x, quick ratio of 1.84x, and cash ratio of 0.52x.

Leverage remains low with debt-to-equity at 0.04x and debt-to-assets at 2.8%, supporting financial flexibility despite negative earnings.

Cash Generation

Free cash flow yield is only 0.7% and price-to-free-cash-flow is elevated at 143.7x, suggesting limited cash return at the current valuation.

Operating cash flow is positive but modest relative to sales, with operating cash flow sales ratio at 2.4%.

Moat Durability

The company shows some structural advantages from very high gross margins and a strong cash position, but the moat is not yet evident in sustained operating profitability.

Heavy SG&A at 67.5% of revenue and R&D at 15.2% of revenue indicate ongoing investment intensity, while negative EBIT and ROIC suggest limited evidence of durable pricing power so far.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Supernus Pharmaceuticals, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →